ArticleHaematologica2023

Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade.

Katharina Woess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.